4th Annual Pharma Innovation Tech Congress 2024

4th Annual Pharma Innovation Tech Congress 2024 is organized by Virtue Insight and will be held on Aug 29, 2024 at Novotel Hyderabad Conventional Centre, Hyderabad, Telangana, India.

Conference Introduction:
The field of Pharmaceuticals has seen significant changes in recent years, with the emergence of new technologies playing a vital role in shaping its future. It’s predicted that the global pharmaceutical technology market size is expected to reach $147.5 billion by 2028. This growth can be attributed to the increasing adoption of digital technologies and platforms in drug discovery and development.

Digitization has the potential to fundamentally transform pharma operations, opening the door to step-change improvements in performance. Pharma companies should get started on this journey, taking immediate steps to digitize their operations and supply chains and develop a strategy and road map for the next three to five years. Those companies that seize the initiative can give themselves a sustainable competitive advantage; operate with greater agility, cost-efficiency, and control; and ultimately provide better care for patients. What’s the new currency for biopharma and life sciences companies? Two words: big data. Take a closer look at how artificial intelligence in the pharmaceutical industry is being used to mine insights from multiple data sets and make it interoperable across the enterprise. AI in supply chain and manufacturing is helping to reshape the pharma value chain and bring life-saving therapies to market faster.

The pharmaceutical industry is at the forefront of artificial intelligence (AI) adoption, harnessing cutting-edge patents to revolutionize drug development and research processes. Despite a decline in patent applications, strategic deals and job opportunities highlight the industry’s commitment to leveraging AI for innovation and efficiency. The impact of AI extends beyond the pharmaceutical sector, influencing various industries. The pharmaceutical business is one of many that is driving digital transformation with blockchain technology. Lack of transparency, difficulty tracking items, a lack of confidence, and the distribution of out-of-date medicines are all problems in the pharmaceutical industry. Several of these issues have been resolved using blockchain technology and we will all find out here in this conference on possible solutions for betterment.

It is high time that we look into innovative strategies, new technologies, effective and quality collaborations to get better in this competitive world with the pharma industry. It gives us immense pleasure in welcoming you to the 4th Annual Pharma Innovation Tech Congress 2024. I wish and pray that all our efforts will be beneficial to our industries and to our country at large.

Key Themes Discussed:
• Where to from here? Disruptive Economics of upcoming Technology
• How will technological trends impact the future of the pharma?
• How is AI steadily transforming the pharma industry?
• Evaluating and enlarging usage of AI and IoT in Pharma World 
• IoMT (Internet of Medical Things) – Framework
• How can AI change Pharma industry? Why, How & When of AI in pharmaceutical industry
• ML in medical devices. How does ML make things easier? 
• AI in manufacturing – what are the risks to be in mind & benefits in the hand?
• Analyzing big opportunities in big data & unblocking new ways in blockchain
• Big Pharma meets Big Data – Analysing innovations
• Why Big Pharma Is Betting on Blockchain?
• Fighting against counterfeiting medicines– Better usage of blockchain
• Digitalisation - How is digital transformation impacting the Pharma Industry?
• Digitized clinical trials – New ways and barriers.
• Challenges and opportunities in moving to digitalisation?
• Transforming lab to smart lab – Path of digitalization
• How do you see the future of smart labs in the next 5 years?
• How does industry 4.0 affect laboratories?
• How is IoT transforming the pharma industry
• Industry game changer: RWE and RWD
• Potential advantages of RWE in clinical studies and regulatory decision making
• Recent regulatory updates